Ramelteon
Top View
- Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington’S Disease—Data from a Real World Cohort
- Belsomra: for the Treatment of Insomnia, Characterized by Difficulties with Sleep Onset And/Or Sleep Maintenance
- List Item Withdrawal Assessment Report for Ramelteon
- Doxepin for Insomnia
- Ramelteon a Novel Hypnotic Lacking Abuse Liability and Sedative Adverse Effects
- Treating Sleep Problems of People in Recovery from Substance Use Disorders
- Psychotropics
- Potentially Harmful Drugs in the Elderly: Beers List and More
- Safer Treatments for Anxiety and Insomnia
- Melatonin and Its Agonists: an Update Josephine Arendt and Shantha M
- PSYCHOTROPIC MEDICATIONS – ASSISTED LIVING Wisconsin Department of Health Services / Division of Quality Assurance P-01806 (05/2017)
- Effect of 1 Month of Zopiclone on Obstructive Sleep Apnoea Severity and Symptoms: a Randomised Controlled Trial
- CP.PMN.173 Ramelteon (Rozerem)
- Patients with a History of Falls and Receiving Tricyclic Antidepressants, Antipsychotics Or Sleep Agents
- Patients with a History of Falls and Receiving Tricyclic Antidepressants, Antipsychotics, Or Sleep Agents
- Review Article
- FDA Requires Lower Recommended Doses for Certain Drugs Containing Zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)
- Medication Guide 2012